Abstract:Intestinal dysbiosis has been shown to be associated with the pathogenesis of alcoholic liver disease (ALD), which includes changes in the microbiota composition and bacterial overgrowth, but an effective microbe-based therapy is lacking. () CGMCC 7049 is a newly isolated strain of probiotic that has been shown to be resistant to ethanol and bile salts. However, further studies are needed to determine whether exerts a protective effect on ALD and to elucidate the potential mechanism.To evaluate the protective effect of the probiotic on ethanol-induced liver injury in mice.A new ethanol-resistant strain of CGMCC 7049 was isolated from healthy adults in our laboratory. The chronic plus binge model of experimental ALD was established to evaluate the protective effects. Twenty-eight C57BL/6 mice were randomly divided into three groups: The control group received a pair-fed control diet and oral gavage with sterile phosphate buffered saline, the EtOH group received a ten-day Lieber-DeCarli diet containing 5% ethanol and oral gavage with phosphate buffered saline, and the group received a 5% ethanol Lieber-DeCarli diet but was treated with . One dose of isocaloric maltose dextrin or ethanol was administered by oral gavage on day 11, and the mice were sacrificed nine hours later. Blood and tissue samples (liver and gut) were harvested to evaluate gut barrier function and liver injury-related parameters. Fresh cecal contents were collected, gas chromatography-mass spectrometry was used to measure short-chain fatty acid (SCFA) concentrations, and the microbiota composition was analyzed using 16S rRNA gene sequencing.The treatment improved ethanol-induced liver injury, with lower alanine aminotransferase, aspartate transaminase and triglyceride levels and decreased neutrophil infiltration. These changes were accompanied by decreased levels of endotoxin and inflammatory cytokines, including interleukin-5, tumor necrosis factor-α, granulocyte colony-stimulating factor, keratinocyte-derived protein chemokine, macrophage inflammatory protein-1α and monocyte chemoattractant protein-1. Ethanol feeding resulted in intestinal dysbiosis and gut barrier disruption, increased relative abundance of potentially pathogenic and , and the depletion of SCFA-producing bacteria, such as , and . In contrast, administration increased the microbial diversity, restored the relative abundance of and and increased propionic acid and butyric acid production by modifying SCFA-producing bacteria. Furthermore, the levels of the tight junction protein ZO-1, mucin proteins (mucin [MUC]-1, MUC-2 and MUC-4) and the antimicrobial peptide Reg3β were increased after probiotic supplementation.Based on these results, the new strain of alleviated ethanol-induced liver injury by reversing gut microbiota dysbiosis, regulating intestinal SCFA metabolism, improving intestinal barrier function, and reducing circulating levels of endotoxin and proinflammatory cytokines and chemokines. Thus, this strain is a potential probiotic treatment for ALD.

Inhibition of Cytochrome P4502E1 by Chlormethiazole Attenuated Acute Ethanol-Induced Fatty Liver.

Cytochrome P4502E1 Inhibitor, Chlormethiazole, Decreases Lipopolysaccharide‐induced Inflammation in Rat Kupffer Cells with Ethanol Treatment

Ethanol-induced Hepatic Steatosis is Modulated by Glycogen Level in the Liver

Cytochrome P450 2E1 Inhibition Prevents Hepatic Carcinogenesis Induced by Diethylnitrosamine in Alcohol-Fed Rats.

Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice.

Inhibition of Cyp2e1 Attenuates Chronic Alcohol Intake-Induced Myocardial Contractile Dysfunction and Apoptosis

Cholesterol Enhances the Toxic Effect of Ethanol and Acetaldehyde in Primary Mouse Hepatocytes

Protective function of cis-mulberroside A and oxyresveratrol from Ramulus mori against ethanol-induced hepatic damage.

Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease

Dietary Synbiotic Supplementation Protects Barrier Integrity of Hepatocytes and Liver Sinusoidal Endothelium in a Mouse Model of Chronic-Binge Ethanol Exposure

Cyanidin-3-O-β-glucoside Protects Against Liver Fibrosis Induced by Alcohol Via Regulating Energy Homeostasis and AMPK/autophagy Signaling Pathway

Fatty Acid Ethyl Ester Synthase Inhibition Ameliorates Ethanol-Induced Ca2+-dependent Mitochondrial Dysfunction and Acute Pancreatitis.

112 18Β-Glycyrrhetinic Acid Prevents Free Fatty Acids/High Fat Diet-Induced Hepatic Toxicity by Inhibiting Cathepsin B Expression and Enzyme Activities

Synergistic effects of combined treatment of 1,2-dichloroethane and high-dose ethanol on liver damage in mice and the related mechanisms

New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism

Quercetin Prevents Ethanol-Induced Dyslipidemia and Mitochondrial Oxidative Damage

Chrysin Modulates Ethanol Metabolism in Wistar Rats: A Promising Role against Organ Toxicities

Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice

CYP2J2-derived EETs Attenuated Ethanol-Induced Myocardial Dysfunction Through Inducing Autophagy and Reducing Apoptosis

Cyanidin-3-O-glucoside Alleviates Ethanol-Induced Liver Injury by Promoting Mitophagy in a Gao-binge Mouse Model of Alcohol-Associated Liver Disease

Multifactorial Comparative Proteomic Study of Cytochrome P450 2e1 Function in Chronic Alcohol Administration